Trince
This company provides a photoporation platform for gentle and efficient cell transfection by using pulsed laser light and photothermal nanosensitizers. The technology creates transient pores in the cell membrane, allowing various payloads like nucleic acids and gene editing complexes to enter the cytosol with minimal impact on cell viability. This method supports high-throughput, scalable applications for both R&D screening and cell therapy manufacturing.
- Biotechnology
Updated 5 months ago
Funding
Raised to date
$6.7MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- This company provides a photoporation platform for gentle and efficient cell transfection by using pulsed laser light and photothermal nanosensitizers. The technology creates transient pores in the cell membrane, allowing various payloads like nucleic acids and gene editing complexes to enter the cytosol with minimal impact on cell viability. This method supports high-throughput, scalable applications for both R&D screening and cell therapy manufacturing.